With biopharma IPOs surging, GoodRx guns for $750M raise

With biopharma IPOs surging, GoodRx guns for $750M raise

Source: 
Endpoints
News Tags: 
snippet: 

Friday, after a week dominated by small-cap offerings like Virios Therapeutics, GoodRx announced they too would try to go public. And although they don’t quite have Pablo Legorreta-like ambitions, the consumer prescription drug platform and drug price watchdog is reportedly still shooting well above Moderna: $750 million.